title: A perspective on pancreatic stem/progenitor cells.
abstract: The prevalence of both type 1 and type 2 diabetes mellitus is increasing throughout the world along with the ensuant morbidity and early mortality because of premature microvascular and macrovascular disease. Current insulin and drug therapies control diabetes, but do not cure it. Cell-based therapies offer the possibilities of a permanent cure for diabetes. Recently, success in the transplantation of pancreatic islets in the livers of type 1 diabetics has afforded the opportunity for a potential cure. However, the severe shortage of donor islets for transplantation limits the usefulness of this therapy. One approach is to exploit the use of stem cells, either embryo-derived or adult tissue-derived, as substrates to create islet tissue suitable for transplantation. Cells isolated from embryo blastocysts and from adult pancreas, liver, and bone marrow can be expanded extensively in vitro and differentiated into islet-like clusters that produce insulin, and, in some instances, can achieve glycemic control when transplanted into streptozotocin-induced diabetic mice. It is, now, also possible to envision the direct systemic administration of stem cells that would home in on and regenerate injured islets, or to administer stem cell stimulators that would enhance endogenous pancreatic stem cells to expand and differentiate into functional, insulin-producing beta-cells. This perspective discusses the potential applications of cellular medicines, in the new discipline of regenerative medicine, to achieve a cure for diabetes.
authors.affiliation: Laboratory of Molecular Endocrinology, Massachusetts General Hospital, 55 Fruit Street - WEL 320, Boston, MA 02114, USA. jhabener@partners.org
authors.forename: Joel F
authors.initials: JF
authors.lastname: Habener
mesh_terms: D000328:Adult; D002454:Cell Differentiation; D002459:Cell Fusion; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000473:pathology* / Q000601:surgery; D006801:Humans; D016035:Pancreas Transplantation; D015995:Prevalence; D033581:Stem Cell Transplantation; D014019:Tissue Donors / Q000706:statistics & numerical data